Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6074 | 1467 | 34.7 | 63% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
261 | 18876 | PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPARIN COFACTOR II | Author keyword | 61 | 54% | 5% | 78 |
2 | ANTITHROMBIN | Author keyword | 43 | 22% | 12% | 174 |
3 | ANTITHROMBIN DEFICIENCY | Author keyword | 31 | 53% | 3% | 42 |
4 | MOL BIOL ORAL DIS | Address | 11 | 22% | 3% | 42 |
5 | HEREDITARY ANTITHROMBIN DEFICIENCY | Author keyword | 8 | 100% | 0% | 5 |
6 | LATENT ANTITHROMBIN | Author keyword | 7 | 67% | 0% | 6 |
7 | REG HEMODONAC | Address | 6 | 21% | 2% | 25 |
8 | RECOMBINANT ANTITHROMBIN | Author keyword | 5 | 63% | 0% | 5 |
9 | RECOMBINANT HUMAN ANTITHROMBIN | Author keyword | 4 | 67% | 0% | 4 |
10 | AT DEFICIENCY | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTI THROMBIN III | 95 | 54% | 8% | 123 |
2 | BETA ANTITHROMBIN | 77 | 96% | 2% | 24 |
3 | HIGH AFFINITY HEPARIN | 53 | 67% | 3% | 48 |
4 | HEREDITARY ABNORMAL ANTITHROMBIN | 46 | 78% | 2% | 31 |
5 | PROTEINASE REACTIONS | 35 | 89% | 1% | 16 |
6 | III DEFICIENCY | 26 | 44% | 3% | 44 |
7 | DEPENDENT INHIBITOR | 21 | 75% | 1% | 15 |
8 | RECOMBINANT ANTITHROMBIN | 20 | 100% | 1% | 9 |
9 | ASN 135 | 17 | 100% | 1% | 8 |
10 | HEPARIN BINDING SITE | 17 | 38% | 2% | 35 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors | 2010 | 26 | 57 | 79% |
Control of the coagulation system by serpins - Getting by with a little help from glycosaminoglycans | 2005 | 75 | 99 | 53% |
INSIGHT INTO THE MECHANISM OF ACTION OF HEPARIN-COFACTOR-II | 1995 | 85 | 61 | 77% |
Antithrombin mutation database: 2nd (1997) update - For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis | 1997 | 155 | 104 | 92% |
The phenotypic and genetic assessment of antithrombin deficiency | 2011 | 12 | 23 | 70% |
Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency An update | 2009 | 29 | 59 | 46% |
THROMBOSIS IN ANTITHROMBIN-III-DEFICIENT PERSONS - REPORT OF A LARGE KINDRED AND LITERATURE-REVIEW | 1992 | 135 | 58 | 93% |
Vascular Dermatan Sulfate and Heparin Cofactor II | 2010 | 11 | 91 | 63% |
SERPIN-GLYCOSAMINOGLYCAN INTERACTIONS | 2011 | 8 | 98 | 54% |
KINETIC CHARACTERIZATION OF HEPARIN-CATALYZED AND UNCATALYZED INHIBITION OF BLOOD-COAGULATION PROTEINASES BY ANTITHROMBIN | 1993 | 176 | 83 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL BIOL ORAL DIS | 11 | 22% | 2.9% | 42 |
2 | REG HEMODONAC | 6 | 21% | 1.7% | 25 |
3 | PROT CONFORMAT ENZYMOL | 4 | 56% | 0.3% | 5 |
4 | PHARMACOL 04 UR 01 09 | 2 | 50% | 0.2% | 3 |
5 | STRUCT MEDTHROMBOSIS UNIT | 2 | 43% | 0.2% | 3 |
6 | VET MED CHEM | 2 | 10% | 1.0% | 14 |
7 | HU MORALES MESEGUER | 1 | 100% | 0.1% | 2 |
8 | PLASMA RD | 1 | 50% | 0.1% | 2 |
9 | UUHSC | 1 | 100% | 0.1% | 2 |
10 | THROMBOSIS UNITCAMBRIDGE MED | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000284023 | PATHOL HSC4N67//LIVER CLEARANCE//SERP 1 |
2 | 0.0000209602 | ACTIVATED PARTIAL THROMBOPLASTIN TIMES//BLUMEA RIPARIA//INTRATHECAL FIBRINOLYSIS |
3 | 0.0000191757 | CELLULAR INHIBITION//INFECT DIS INVEST SCI//PENTOSAN POLYSULPHATE SODIUM |
4 | 0.0000147470 | PROTEIN C INHIBITOR//MCFD2//F5F8D |
5 | 0.0000107262 | ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ANTITRYPSIN |
6 | 0.0000098338 | PROTEIN Z//PROTEIN Z DEPENDENT PROTEASE INHIBITOR//PROTEIN Z DEFICIENCY |
7 | 0.0000094060 | HISTIDINE RICH GLYCOPROTEIN//HRG//HISTIDINE PROLINE RICH GLYCOPROTEIN |
8 | 0.0000091169 | HEPARAN SULFATE//OVERSULFATED CHONDROITIN SULFATE//HEPAROSAN |
9 | 0.0000090494 | PROTEIN S//PROTEIN C DEFICIENCY//C4B BINDING PROTEIN |
10 | 0.0000090364 | HEPARIN RESISTANCE//ACTIVATED CLOTTING TIME//ACTIVATED COAGULATION TIME |